This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2003
Title: Innovations of Fernand-Pierre Gendron
Introduction
Fernand-Pierre Gendron is a notable inventor based in Trois-Rivières, Canada. He has made significant contributions to the field of biochemistry, particularly through his innovative work on nucleotide analogs. His research has implications for various biological processes and therapeutic applications.
Latest Patents
Gendron holds a patent for C8-substituted purine nucleotide analogs. This patent describes the use of ATP analogs and their role as inhibitors of NTPDases. These analogs serve as tools to modulate the conversion of nucleotides into nucleoside derivatives. Such modulation can influence the levels of these compounds, thereby affecting numerous biological processes.
Career Highlights
Throughout his career, Gendron has focused on the intersection of chemistry and biology. His work has led to advancements in understanding how nucleotide analogs can be utilized in therapeutic contexts. He has demonstrated a commitment to research that bridges fundamental science and practical applications.
Collaborations
Gendron has collaborated with notable colleagues, including Bilha Fischer and Efrat Halbfinger. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Fernand-Pierre Gendron's contributions to the field of nucleotide analogs highlight his role as an influential inventor. His work continues to pave the way for advancements in biochemistry and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile